Unique Cells Found in Lung Cancer Patients may Predict Survival Lung cancer is the leading cause of cancer-related deaths in the U.S. Most who are diagnosed with lung cancer do not survive five years. Non-small cell lung cancer (NSCLC) is the most common type, where tumor cells shed from the
Unlocking Therapies for Hard-to-Treat Lung Cancers Around 85 percent of lung cancers are classified as non-small-cell lung cancers, or NSCLCs. Some patients with these cancers can be treated with targeted genetic therapies, and some benefit from immunotherapies—but the vast majority of NSCLC patients have no treatment options except for chemotherapy.